The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First interim analysis of the SirTac trial: A randomized phase II study of SIRT and DSM-TACE in patients with liver metastases from uveal melanoma.
 
Caroline-Anna Anna Peuker
Honoraria - Bristol Myers Squibb Foundation
Consulting or Advisory Role - Novartis
Research Funding - Novartis; Pharmacept; Sirtex Medical
Travel, Accommodations, Expenses - Janssen-Cilag
 
Maximilian De Bucourt
Honoraria - 3D Systems; Abbott Biotherapeutics; AstraZeneca/Merck; Bayer; Biotronik International; Boston Scientific Foundation; Canon Medical System; Cardinal Health; Delcath Systems; Fresenius Biotech; Guerbet; Inari Medical; Johnson & Johnson/CERENOVUS; Kinepict; Medtronic; Mentice; Merit Medical Systems; MOLOGEN; Novartis; Parexel; Penumbra; Pfizer; PharmaCept; Roche; Siemens Healthcare Diagnostics; Straub Medical AG
Consulting or Advisory Role - 3D Systems; Abbott Biotherapeutics; AstraZeneca/Merck; Bayer; Biotronik International; Boston Scientific Foundation; Canon Medical System; Cardinal Health; Delcath Systems; Fresenius Biotech; Guerbet; Inari Medical; Johnson & Johnson/CERENOVUS; Kinepict; Medtronic; Mentice; Merit Medical Systems; MOLOGEN; Novartis; Parexel; Penumbra; Pfizer; PharmaCept; Roche; Siemens Healthcare Diagnostics; Straub Medical AG
Research Funding - 3D Systems (Inst); Abbott Biotherapeutics (Inst); AstraZeneca/Merck (Inst); Bayer (Inst); Biotronik International (Inst); Boston Scientific Foundation (Inst); Canon Medical System (Inst); Cardinal Health (Inst); Delcath Systems (Inst); Fresenius Biotech (Inst); Guerbet (Inst); Inari Medical (Inst); Johnson & Johnson/CERENOVUS (Inst); Kinepict (Inst); Medtronic (Inst); Mentice (Inst); Merit Medical Systems (Inst); MOLOGEN (Inst); Novartis (Inst); Parexel (Inst); Penumbra (Inst); Pfizer (Inst); PharmaCept (Inst); Roche (Inst); Siemens Healthcare Diagnostics (Inst); Straub Medical AG (Inst)
 
Bernhard Gebauer
Honoraria - AngioDynamics (Inst); Bayer (Inst); Beacon Bioscience/ICON Medical (Inst); Boston Scientific (Inst); C.R. BARD/BD (Inst); Cook Biotech (Inst); Eisai (Inst); Ewimed (Inst); Guerbet (Inst); INARI (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Parexel/Calyx (Inst); Pfizer (Inst); PharmaCept (Inst); Roche (Inst); Sirtex Medical (Inst); St. Jude Medical (Inst); TERUMO (Inst)
 
Holger Amthauer
Honoraria - Pfizer; Sirtex Medical
Consulting or Advisory Role - Pfizer; TERUMO
 
Christoph Erxleben
No Relationships to Disclose
 
Jan Eucker
No Relationships to Disclose
 
Ulrich Keller
Consulting or Advisory Role - Amgen; AstraZeneca/Merck; Bristol-Myers Squibb; Celgene; EUSA Pharma; Gilead Sciences; Hexal; Janssen-Cilag; MSD; Novartis; Pentixapharm; Roche; Takeda
 
Serge Leyvraz
Consulting or Advisory Role - Bayer; Immunocore
Travel, Accommodations, Expenses - Bayer; Immunocore
 
Antonia M. Joussen
No Relationships to Disclose
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck KGaA; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology
Speakers' Bureau - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; BMS; Janssen-Cilag; Merck Serono; MSD
Research Funding - BMS
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - BMS; Merck Serono